Literature DB >> 18720225

Sickle red cell-endothelium interactions.

Dhananjay K Kaul1, Eileen Finnegan, Gilda A Barabino.   

Abstract

Periodic recurrence of painful vaso-occlusive crisis is the defining feature of sickle cell disease. Among multiple pathologies associated with this disease, sickle red cell-endothelium interaction has been implicated as a potential initiating mechanism in vaso-occlusive events. This review focuses on various interrelated mechanisms involved in human sickle red cell adhesion. We discuss in vitro and microcirculatory findings on sickle red cell adhesion, its potential role in vaso-occlusion, and the current understanding of receptor-ligand interactions involved in this pathological phenomenon. In addition, we discuss the contribution of other cellular interactions (leukocytes recruitment and leukocyte-red cell interaction) to vaso-occlusion, as observed in transgenic sickle mouse models. Emphasis is given to recently discovered adhesion molecules that play a predominant role in mediating human sickle red cell adhesion. Finally, we analyze various therapeutic approaches for inhibiting sickle red cell adhesion by targeting adhesion molecules and also consider therapeutic strategies that target stimuli involved in endothelial activation and initiation of adhesion.

Entities:  

Mesh:

Year:  2009        PMID: 18720225      PMCID: PMC3059190          DOI: 10.1080/10739680802279394

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  83 in total

1.  Sickle cell anemia as an inflammatory disease.

Authors:  O S Platt
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice.

Authors:  D K Kaul; R P Hebbel
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 3.  Blockade of adhesion of sickle cells to endothelium by monoclonal antibodies.

Authors:  R P Hebbel
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

4.  Nitric oxide attenuates normal and sickle red blood cell adherence to pulmonary endothelium.

Authors:  S L Space; P A Lane; C K Pickett; J V Weil
Journal:  Am J Hematol       Date:  2000-04       Impact factor: 10.047

5.  Second generation knockout sickle mice: the effect of HbF.

Authors:  M E Fabry; S M Suzuka; R S Weinberg; C Lawrence; S M Factor; J G Gilman; F Costantini; R L Nagel
Journal:  Blood       Date:  2001-01-15       Impact factor: 22.113

6.  Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor.

Authors:  D K Kaul; H M Tsai; X D Liu; M T Nakada; R L Nagel; B S Coller
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

7.  Identification of the platelet ADP receptor targeted by antithrombotic drugs.

Authors:  G Hollopeter; H M Jantzen; D Vincent; G Li; L England; V Ramakrishnan; R B Yang; P Nurden; A Nurden; D Julius; P B Conley
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

8.  Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion.

Authors:  Eileen M Finnegan; Aslihan Turhan; David E Golan; Gilda A Barabino
Journal:  Am J Hematol       Date:  2007-04       Impact factor: 10.047

9.  Small-molecule cyclic alpha V beta 3 antagonists inhibit sickle red cell adhesion to vascular endothelium and vasoocclusion.

Authors:  Eileen M Finnegan; Gilda A Barabino; Xiao-du Liu; Hee-Yoon Chang; Alfred Jonczyk; Dhananjay K Kaul
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-05-04       Impact factor: 4.733

10.  Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin.

Authors:  José Villagra; Sruti Shiva; Lori A Hunter; Roberto F Machado; Mark T Gladwin; Gregory J Kato
Journal:  Blood       Date:  2007-05-29       Impact factor: 22.113

View more
  49 in total

1.  Red blood cell storage and transfusion-related immunomodulation.

Authors:  Rosemary L Sparrow
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

Review 2.  Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology.

Authors:  Dachuan Zhang; Chunliang Xu; Deepa Manwani; Paul S Frenette
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

3.  Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies.

Authors:  Deepa Manwani; Paul S Frenette
Journal:  Blood       Date:  2013-09-19       Impact factor: 22.113

4.  Kinetics of sickle cell biorheology and implications for painful vasoocclusive crisis.

Authors:  E Du; Monica Diez-Silva; Gregory J Kato; Ming Dao; Subra Suresh
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

Review 5.  Pathophysiology of Sickle Cell Disease.

Authors:  Prithu Sundd; Mark T Gladwin; Enrico M Novelli
Journal:  Annu Rev Pathol       Date:  2018-10-17       Impact factor: 23.472

6.  Quantifying Shear-Induced Deformation and Detachment of Individual Adherent Sickle Red Blood Cells.

Authors:  Yixiang Deng; Dimitrios P Papageorgiou; Hung-Yu Chang; Sabia Z Abidi; Xuejin Li; Ming Dao; George Em Karniadakis
Journal:  Biophys J       Date:  2018-12-18       Impact factor: 4.033

7.  Endothelial activation and inflammation biomarkers in children and adolescents with sickle cell disease.

Authors:  Emmanuil S Hatzipantelis; Zoe Dorothea Pana; N Gombakis; A Taparkou; V Tzimouli; D Kleta; D J Zafeiriou; V Garipidou; F Kanakoudi; M Athanassiou
Journal:  Int J Hematol       Date:  2013-06-27       Impact factor: 2.490

8.  Haploidentical stem cell transplantation with CD3+-/CD19+- depleted peripheral stem cells for patients with advanced stage sickle cell disease and no alternative donor: results of a pilot study.

Authors:  J Foell; B Pfirstinger; K Rehe; D Wolff; E Holler; S Corbacioglu
Journal:  Bone Marrow Transplant       Date:  2017-04-24       Impact factor: 5.483

9.  Red Blood Cell Adhesion to Heme-Activated Endothelial Cells Reflects Clinical Phenotype in Sickle Cell Disease.

Authors:  Erdem Kucukal; Anton Ilich; Nigel S Key; Jane A Little; Umut A Gurkan
Journal:  Am J Hematol       Date:  2018-06-15       Impact factor: 10.047

Review 10.  State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.

Authors:  Latika Puri; Kerri A Nottage; Jane S Hankins; Doralina L Anghelescu
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.